CompaniesLiving Cell Technologies

Living Cell Technologies

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

3

As Collaborator

0

Total Enrollment

36

By Phase

PHASE2: 2PHASE1/PHASE2: 1

By Status

COMPLETED: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Today
NCT01736228
NCT01734733
NCT02683629
Hover over trial bars to see details

Recent Trials

NCT02683629Lead Sponsor
Investigation of the Safety and Efficacy of NTCELL® [Immunoprotected (Alginate-Encapsulated) Porcine Choroid Plexus Cells for Xenotransplantation] in Patients With Parkinson's Disease
PHASE2Completed
18 participants
Started: Feb 29, 2016 · Completed: May 2, 2019
NCT01734733Lead Sponsor
Open-label Investigation of the Safety and Clinical Effects of NTCELL in Patients With Parkinson's Disease
PHASE1/PHASE2Completed
4 participants
Started: Jul 12, 2013 · Completed: Jun 4, 2020
NCT01736228Lead Sponsor
Open-label Investigation of the Safety and Efficacy of DIABECELL in Patients With Type 1 Diabetes Mellitus
PHASE2Completed
14 participants
Started: Nov 30, 2012 · Completed: Dec 31, 2014
Funding History (2)
D/A
Jan 18, 2011
Filing
D
Jan 13, 2011
Filing